3 March 2025
Depemokimab applications accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (CRSwNP) GSK plc (LSE/NYSE:…
HICL Infrastructure PLC “HICL” or the “Company” and, together with its corporate subsidiaries, the “Group”, the London-listed infrastructure investment company managed by InfraRed Capital…
Assura plc (“Assura” or the “Company”) Assura achieves £200m disposal milestone Assura plc, the UK’s leading diversified healthcare REIT, is pleased to announce it has…
LONDONMETRIC PROPERTY PLC Occupational activity adds £13.2 million of annual rental income LondonMetric Property Plc (“LondonMetric”) announces that since 30 September 2024 it has…
ANNUAL RESULTS ANNOUNCEMENT Record acquisition spend, three year capital allocation commitment and 2025 guidance unchanged Bunzl plc, the specialist international distribution and services Group, today…
Imfinzi-based perioperative regimen recommended for approval in the EU by CHMP for resectable non-small cell lung cancer Recommendation based on AEGEAN Phase III trial results…
28 February 2025
Primary Health Properties PLC Preliminary results for the year ended 31 December 2024 29-year track record of dividend growth set to continue as new…
JPMORGAN GLOBAL GROWTH & INCOME PLC UNAUDITED HALF YEAR RESULTS FOR THE SIX MONTHS ENDED 31st DECEMBER 2024 JPMorgan Global Growth & Income plc…